ESTA EBITDA | Establishment Labs Holdings Inc.

ESTABLISHMENT LABS HOLDINGS INC. EBITDA

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of the cash a company's operations generate before accounting charges for wearing out its assets. Here it is operating income plus the filed depreciation and amortization, not a figure the company adjusted itself. Higher EBITDA means more operating profit before those charges. It is not an official accounting (GAAP) measure and does not subtract capital spending, interest or tax, so it does not show what those obligations cost.

ESTABLISHMENT LABS HOLDINGS INC. ebitda for the quarter ending 2026-03-31 was -$4.91M, a change of $10.44M year-over-year.
ESTABLISHMENT LABS HOLDINGS INC. ebitda for the quarter ending 2025-12-31 was -$2.43M, a change of $14.74M year-over-year.
ESTABLISHMENT LABS HOLDINGS INC. ebitda for the quarter ending 2025-09-30 was -$2.53M, a change of $9.31M year-over-year.
ESTABLISHMENT LABS HOLDINGS INC. ebitda for the quarter ending 2025-06-30 was -$12.51M, a change of -$4.06M year-over-year.
ESTABLISHMENT LABS HOLDINGS INC. ebitda for fiscal 2025 was -$32.81M, a change of $12.48M from fiscal 2024.
ESTABLISHMENT LABS HOLDINGS INC. ebitda for fiscal 2024 was -$45.29M, a change of $16.94M from fiscal 2023.
ESTABLISHMENT LABS HOLDINGS INC. ebitda for fiscal 2023 was -$62.23M, a change of -$25.07M from fiscal 2022.
ESTABLISHMENT LABS HOLDINGS INC. ebitda for fiscal 2022 was -$37.16M, a change of -$14.52M from fiscal 2021.

Available history: 2018-03-31 to 2026-03-31
Data captured: 2026-03-31

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$4.29M	(m)	$67.54M	(m)	$3.66M*	-$16.60M*	(m)	$5.10M	$46.91M	$6.00K
2026-03-31	Reported	-$4.91M	-$6.51M	$1.6M	(m)	-8.20%	$1.85M	-$4.31M	(m)	$5.24M	$43.60M	$288.00K
2025-12-31	Reported	-$2.43M	-$3.93M	$1.5M	(m)	-3.76%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$2.53M	-$4.03M	$1.5M	(m)	-4.69%	$1.85M*	-$11.25M*	(m)	$4.55M	$37.17M	$424.00K
2025-06-30	Reported	-$12.51M	-$14.11M	$1.6M	(m)	-24.38%	$1.62M*	-$18.75M*	(m)	$5.20M	$44.18M	$1.00M
2025-03-31	Reported	-$15.35M	-$16.95M	$1.6M	(m)	-37.09%	$753.00K	-$20.73M	(m)	$5.05M	$39.70M	$914.00K
2024-12-31	Reported	-$17.17M	-$18.67M	$1.5M	(m)	-38.57%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$11.84M	-$13.14M	$1.3M	(m)	-29.43%	$1.47M*	-$12.46M*	(m)	$4.80M	$34.05M	$510.00K
2024-06-30	Reported	-$8.44M	-$9.34M	$900,000.00	(m)	-19.14%	$798.00K*	-$14.15M*	(m)	$5.49M	$32.79M	$428.00K
2024-03-31	Reported	-$7.93M	-$8.83M	$900,000.00	(m)	-21.35%	$3.31M	-$11.15M	(m)	$4.27M	$28.94M	$438.00K
2023-12-31	Reported	-$21.32M	-$22.12M	$800,000.00	(m)	-67.54%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$20.34M	-$21.04M	$700,000.00	(m)	-52.82%	$3.70M*	-$31.51M*	(m)	$7.13M	$39.96M	$669.00K
2023-06-30	Reported	-$13.11M	-$13.71M	$600,000.00	(m)	-27.00%	$3.12M*	-$28.24M*	(m)	$6.95M	$37.03M	$925.00K
2023-03-31	Reported	-$7.56M	-$8.16M	$600,000.00	(m)	-16.25%	$432.00K	-$20.61M	(m)	$6.53M	$31.71M	$830.00K
2022-12-31	Reported	-$12.56M	-$13.16M	$600,000.00	(m)	-28.67%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$9.82M	-$10.52M	$700,000.00	(m)	-25.67%	$480.00K*	-$21.98M*	(m)	$5.29M	$31.27M	$603.00K
2022-06-30	Reported	-$9.81M	-$10.41M	$600,000.00	(m)	-23.81%	$607.00K*	-$11.33M*	(m)	$4.90M	$32.96M	$564.00K
2022-03-31	Reported	-$5.25M	-$5.58M	$325,000.00	(m)	(m)	$798.00K	-$4.84M	(m)	$3.60M	$26.91M	$399.00K
2021-09-30	Reported	-$8.71M	-$9.04M	$330,000.00	(m)	(m)	$963.00K*	-$12.46M*	(m)	$3.88M	$24.78M	$66.00K
2021-06-30	Reported	-$4.3M	-$4.63M	$332,000.00	(m)	(m)	$900.00K*	-$814.00K*	(m)	$4.35M	$21.75M	$408.00K
2021-03-31	Reported	-$1.75M	-$2.1M	$343,000.00	(m)	(m)	$804.00K	-$6.55M	(m)	$4.05M	$18.14M	$165.00K
2020-09-30	Reported	-$2.37M	-$2.59M	$220,000.00	(m)	(m)	$846.00K*	-$3.05M*	(m)	$2.73M	$15.01M	$181.00K
2020-06-30	Reported	-$9.38M	-$9.6M	$221,000.00	(m)	(m)	$603.00K*	-$6.09M*	(m)	$2.40M	$14.44M	$194.00K
2020-03-31	Reported	-$7.49M	-$7.71M	$220,000.00	(m)	(m)	$687.00K	-$6.80M	(m)	$4.20M	$18.98M	$231.00K
2019-09-30	Reported	-$8.54M	-$8.77M	$221,000.00	(m)	(m)	$741.00K*	-$10.90M*	(m)	$3.78M	$19.23M	$308.00K
2019-06-30	Reported	-$9.16M	-$9.38M	$221,000.00	(m)	(m)	$4.20M*	-$7.06M*	(m)	$4.00M	$18.39M	$35.00K
2019-03-31	Reported	-$8.17M	-$8.39M	$221,000.00	(m)	(m)	$685.00K	-$8.00M	(m)	$3.58M	$16.06M	$44.00K
2018-09-30	Reported	-$5.83M	-$6.05M	$221,000.00	(m)	(m)	$561.00K*	-$10.49M*	(m)	$3.17M	$12.98M	-$99.00K
2018-06-30	Reported	-$6.19M	-$6.32M	$124,000.00	(m)	(m)	$306.00K*	-$8.98M*	(m)	$3.71M	$10.83M	$152.00K
2018-03-31	Reported	-$2.66M	-$2.88M	$224,000.00	(m)	(m)	$392.00K	-$5.93M	(m)	$2.15M	$8.65M	$10.00K
2017-09-30	Reported	(m)	-$5.97M	(m)	(m)	(m)	$372.00K*	-$9.03M*	(m)	$1.44M	$8.14M	$31.00K
2017-06-30	Reported	(m)	-$5.48M	(m)	(m)	(m)	(m)	(m)	(m)	$1.48M	$8.13M	$0.00

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$32.81M	-$39.01M	$6.2M	(m)	-15.54%	$6.05M	-$50.89M	(m)	$20.25M	$165.07M	-$6.96M
2024-12-31	Reported	-$45.29M	-$49.99M	$4.7M	(m)	-27.28%	$6.11M	-$58.52M	(m)	$19.71M	$139.81M	-$32.00K
2023-12-31	Reported	-$62.23M	-$65.03M	$2.8M	(m)	-37.68%	$7.91M	-$88.51M	(m)	$26.43M	$145.57M	-$81.00K
2022-12-31	Reported	-$37.16M	-$39.66M	$2.5M	(m)	-22.98%	$2.85M	-$52.17M	(m)	$20.27M	$125.98M	$2.38M
2021-12-31	Reported	-$22.64M	-$25.14M	$2.5M	(m)	-17.87%	$2.42M	-$27.53M	(m)	$18.32M	$92.23M	$1.43M
2020-12-31	Reported	(m)	-$27.92M	(m)	$84.68M	(m)	$2.11M	-$12.51M	(m)	$13.79M	$66.63M	$104.00K
2019-12-31	Reported	(m)	-$30.94M	(m)	$89.56M	(m)	$6.29M	-$29.98M	(m)	$14.99M	$70.81M	$640.00K
2018-12-31	Reported	(m)	-$23.86M	(m)	$61.21M	(m)	$1.73M	-$33.88M	(m)	$12.69M	$47.30M	$215.00K
2017-12-31	Reported	(m)	-$19.98M	(m)	(m)	(m)	$901.00K	-$31.97M	(m)	$6.86M	$30.82M	$105.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Cadre Holdings, Inc. (CDRE)	United States	$1.123B	33.88
Enovis CORP (ENOV)	United States	$1.053B	-1.18
Anteris Technologies Global Corp. (AVR)	United States	$0.746B
Sanara MedTech Inc. (SMTI)	United States	$0.323B	-6.81
Inogen Inc (INGN)	United States	$0.139B	-7.00
Conexeu Sciences Inc. (CNXU)	United States	$0.111B
NutriBand Inc. (NTRB)	United States	$0.109B
LAKELAND INDUSTRIES INC (LAKE)	United States	$0.104B	-4.21
Safe Pro Group Inc. (SPAI)	United States	$0.090B
MYOMO, INC. (MYO)	United States	$0.065B	-2.85